Published in PLoS Med on July 10, 2012
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Antiretroviral Therapy for the Prevention of HIV-1 Transmission. N Engl J Med (2016) 3.71
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31
HIV treatment as prevention: debate and commentary--will early infection compromise treatment-as-prevention strategies? PLoS Med (2012) 1.76
HPTN 071 (PopART): a cluster-randomized trial of the population impact of an HIV combination prevention intervention including universal testing and treatment: mathematical model. PLoS One (2014) 1.66
HIV treatment as prevention: models, data, and questions--towards evidence-based decision-making. PLoS Med (2012) 1.62
HIV treatment as prevention: the utility and limitations of ecological observation. PLoS Med (2012) 1.55
Combination prevention: new hope for stopping the epidemic. Curr HIV/AIDS Rep (2013) 1.36
Why the proportion of transmission during early-stage HIV infection does not predict the long-term impact of treatment on HIV incidence. Proc Natl Acad Sci U S A (2014) 1.13
HIV treatment as prevention: issues in economic evaluation. PLoS Med (2012) 1.10
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08
Phylogenetic studies of transmission dynamics in generalized HIV epidemics: an essential tool where the burden is greatest? J Acquir Immune Defic Syndr (2014) 1.03
Advances in HIV prevention for serodiscordant couples. Curr HIV/AIDS Rep (2014) 1.02
Toward an endgame: finding and engaging people unaware of their HIV-1 infection in treatment and prevention. AIDS Res Hum Retroviruses (2014) 0.96
Biomedical prevention: state of the science. Clin Infect Dis (2014) 0.89
Health benefits, costs, and cost-effectiveness of earlier eligibility for adult antiretroviral therapy and expanded treatment coverage: a combined analysis of 12 mathematical models. Lancet Glob Health (2013) 0.87
A role for health communication in the continuum of HIV care, treatment, and prevention. J Acquir Immune Defic Syndr (2014) 0.86
Can we stop AIDS with antiretroviral-based treatment as prevention? Glob Health Sci Pract (2013) 0.85
Linkage of viral sequences among HIV-infected village residents in Botswana: estimation of linkage rates in the presence of missing data. PLoS Comput Biol (2014) 0.82
Can the Heterosexual HIV Epidemic be Eliminated in South Africa Using Combination Prevention? A Modeling Analysis. Am J Epidemiol (2016) 0.78
CD4+ cell dynamics in untreated HIV-1 infection: overall rates, and effects of age, viral load, sex and calendar time. AIDS (2015) 0.78
Sampling Networks from Their Posterior Predictive Distribution. Netw Sci (Camb Univ Press) (2014) 0.78
Intra-Cluster Correlation Estimates for HIV-related Outcomes from Care and Treatment Clinics in Dar es Salaam, Tanzania. Contemp Clin Trials Commun (2016) 0.77
The impact of the 2013 WHO antiretroviral therapy guidelines on the feasibility of HIV population prevention trials. HIV Clin Trials (2014) 0.77
Policy makers, the international community and the population in the prevention and treatment of diseases: case study on HIV/AIDS. Health Econ Rev (2017) 0.75
Sample size considerations using mathematical models: an example with Chlamydia trachomatis infection and its sequelae pelvic inflammatory disease. BMC Infect Dis (2015) 0.75
Displacement of sexual partnerships in trials of sexual behavior interventions: A model-based assessment of consequences. Epidemics (2017) 0.75
Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet (2008) 36.01
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Episodic sexual transmission of HIV revealed by molecular phylodynamics. PLoS Med (2008) 4.76
Adaptive designs in clinical drug development--an Executive Summary of the PhRMA Working Group. J Biopharm Stat (2006) 4.41
Weighing the gold in the gold standard: challenges in HIV prevention research. AIDS (2010) 4.20
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05
Study designs for dependent happenings. Epidemiology (1991) 3.58
Understanding the impact of male circumcision interventions on the spread of HIV in southern Africa. PLoS One (2008) 3.32
Adaptive design methods in clinical trials - a review. Orphanet J Rare Dis (2008) 2.88
Modelling the impact of antiretroviral use in resource-poor settings. PLoS Med (2006) 2.52
Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res (2011) 2.45
Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05
Assessing evidence for behaviour change affecting the course of HIV epidemics: a new mathematical modelling approach and application to data from Zimbabwe. Epidemics (2009) 2.05
Factors controlling the spread of HIV in heterosexual communities in developing countries: patterns of mixing between different age and sexual activity classes. Philos Trans R Soc Lond B Biol Sci (1993) 2.04
The effectiveness of HIV prevention and the epidemiological context. Bull World Health Organ (2001) 1.98
Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav (2011) 1.95
The impact of HIV epidemic phases on the effectiveness of core group interventions: insights from mathematical models. Sex Transm Infect (2002) 1.69
Type of partnership and heterosexual spread of HIV infection in rural Uganda: results from simulation modelling. Int J STD AIDS (1999) 1.50
Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS (2000) 1.50
Does sex in the early period after circumcision increase HIV-seroconversion risk? Pooled analysis of adult male circumcision clinical trials. AIDS (2009) 1.48
Economic evaluation of vaccination programs: the impact of herd-immunity. Med Decis Making (2003) 1.47
Interim modelling analysis to validate reported increases in condom use and assess HIV infections averted among female sex workers and clients in southern India following a targeted HIV prevention programme. Sex Transm Infect (2010) 1.38
HIV treatment as prevention: modelling the cost of antiretroviral treatment--state of the art and future directions. PLoS Med (2012) 1.29
Evaluating large-scale HIV prevention interventions: study design for an integrated mathematical modelling approach. Sex Transm Infect (2007) 1.28
Mind the gap: the role of time between sex with two consecutive partners on the transmission dynamics of gonorrhea. Sex Transm Dis (2008) 1.19
The importance of context: model projections on how microbicide impact could be affected by the underlying epidemiologic and behavioral situation in 2 African settings. Sex Transm Dis (2006) 1.10
Neglected issues and hypotheses regarding the impact of sexual concurrency on HIV and sexually transmitted infections. AIDS Behav (2012) 1.00
Measuring effectiveness in community randomized trials of HIV prevention. Int J Epidemiol (2007) 0.98
A Bayesian approach to uncertainty analysis of sexually transmitted infection models. Sex Transm Infect (2009) 0.96
Incremental role of male circumcision on a generalised HIV epidemic through its protective effect against other sexually transmitted infections: from efficacy to effectiveness to population-level impact. Sex Transm Infect (2008) 0.96
Complementary hypothesis concerning the community sexually transmitted disease mass treatment puzzle in Rakai, Uganda. AIDS (2000) 0.96
Measuring the public-health impact of candidate HIV vaccines as part of the licensing process. Lancet Infect Dis (2008) 0.95
Adaptive methods: telling "the rest of the story". J Biopharm Stat (2010) 0.93
Interim monitoring of longitudinal comparative studies with recurrent event responses. Biometrics (1996) 0.93
HIV prevention. Halting HIV/AIDS epidemics. Science (2011) 0.91
Community randomized trials for HIV prevention: the past, a lesson for the future? AIDS (2003) 0.89
Some important issues in the planning of phase III HIV vaccine efficacy trials. Vaccine (1999) 0.86
Antiretroviral therapy initiated soon after HIV diagnosis as standard care: potential to save lives? HIV AIDS (Auckl) (2011) 0.81
Group sequential methods for cluster randomization trials with binary outcomes. Clin Trials (2005) 0.80
Towards an improved investment approach for an effective response to HIV/AIDS. Lancet (2011) 11.89
Effectiveness of COL-1492, a nonoxynol-9 vaginal gel, on HIV-1 transmission in female sex workers: a randomised controlled trial. Lancet (2002) 11.02
Tenofovir-based preexposure prophylaxis for HIV infection among African women. N Engl J Med (2015) 9.20
Young people's sexual health in South Africa: HIV prevalence and sexual behaviors from a nationally representative household survey. AIDS (2005) 8.71
HIV decline associated with behavior change in eastern Zimbabwe. Science (2006) 6.98
HIV and risk environment for injecting drug users: the past, present, and future. Lancet (2010) 4.77
Safety and tolerability of tenofovir vaginal gel in abstinent and sexually active HIV-infected and uninfected women. AIDS (2006) 4.23
HIV treatment as prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med (2012) 4.08
Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS (2010) 4.05
Implementation science for the US President's Emergency Plan for AIDS Relief (PEPFAR). J Acquir Immune Defic Syndr (2011) 3.77
A decline in new HIV infections in South Africa: estimating HIV incidence from three national HIV surveys in 2002, 2005 and 2008. PLoS One (2010) 3.38
Sexual power and HIV risk, South Africa. Emerg Infect Dis (2004) 3.31
Early age of first sex: a risk factor for HIV infection among women in Zimbabwe. AIDS (2004) 3.30
Effects of unconditional and conditional cash transfers on child health and development in Zimbabwe: a cluster-randomised trial. Lancet (2013) 2.98
HIV decline in Zimbabwe due to reductions in risky sex? Evidence from a comprehensive epidemiological review. Int J Epidemiol (2010) 2.96
Safety and effectiveness of BufferGel and 0.5% PRO2000 gel for the prevention of HIV infection in women. AIDS (2011) 2.86
Job strain and risk of acute recurrent coronary heart disease events. JAMA (2007) 2.61
Biomarker validation of reports of recent sexual activity: results of a randomized controlled study in Zimbabwe. Am J Epidemiol (2009) 2.57
Incident and prevalent herpes simplex virus type 2 infection increases risk of HIV acquisition among women in Uganda and Zimbabwe. AIDS (2007) 2.35
Antiretroviral treatment of HIV-1 prevents transmission of HIV-1: where do we go from here? Lancet (2013) 2.31
Insulin-like growth factor-I, IGF-binding protein-3, and mammographic breast density. Cancer Epidemiol Biomarkers Prev (2005) 2.28
A surprising prevention success: why did the HIV epidemic decline in Zimbabwe? PLoS Med (2011) 2.23
Determinants and consequences of sexual networks as they affect the spread of sexually transmitted infections. J Infect Dis (2005) 2.23
Mathematical models in the evaluation of health programmes. Lancet (2011) 2.05
A randomized trial of antioxidant vitamins to prevent second primary cancers in head and neck cancer patients. J Natl Cancer Inst (2005) 2.04
Poverty, gender inequities, and women's risk of human immunodeficiency virus/AIDS. Ann N Y Acad Sci (2007) 2.02
Keep them in school: the importance of education as a protective factor against HIV infection among young South African women. Int J Epidemiol (2008) 2.00
Concurrent sexual partnerships and primary HIV infection: a critical interaction. AIDS Behav (2011) 1.95
uPM3, a new molecular urine test for the detection of prostate cancer. Urology (2004) 1.91
Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study. AIDS (2013) 1.88
The new role of antiretrovirals in combination HIV prevention: a mathematical modelling analysis. AIDS (2013) 1.81
Distinct HIV discordancy patterns by epidemic size in stable sexual partnerships in sub-Saharan Africa. Sex Transm Infect (2012) 1.81
Bacterial vaginosis and vaginal yeast, but not vaginal cleansing, increase HIV-1 acquisition in African women. J Acquir Immune Defic Syndr (2008) 1.80
Wage losses in the year after breast cancer: extent and determinants among Canadian women. J Natl Cancer Inst (2008) 1.80
Sexual bridging socially and over time: a simulation model exploring the relative effects of mixing and concurrency on viral sexually transmitted infection transmission. Sex Transm Dis (2006) 1.78
Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis. Lancet HIV (2015) 1.77
Elimination of HIV in South Africa through expanded access to antiretroviral therapy: a model comparison study. PLoS Med (2013) 1.73
Impact of sexual networks on risk for gonorrhea and chlamydia among low-income urban African American adolescents. J Pediatr (2005) 1.71
Do changes in spousal employment status lead to domestic violence? Insights from a prospective study in Bangalore, India. Soc Sci Med (2009) 1.66
A community-based study to examine the effect of a youth HIV prevention intervention on young people aged 15-24 in South Africa: results of the baseline survey. Trop Med Int Health (2005) 1.65
Migration, sexual behaviour, and HIV risk: a general population cohort in rural South Africa. Lancet HIV (2015) 1.63
Sexual network structure among a household sample of urban african american adolescents in an endemic sexually transmitted infection setting. Sex Transm Dis (2009) 1.61
Improvements in prevalence trend fitting and incidence estimation in EPP 2013. AIDS (2014) 1.58
Sex with stitches: assessing the resumption of sexual activity during the postcircumcision wound-healing period. AIDS (2012) 1.54
Safety and acceptability of cellulose sulfate as a vaginal microbicide in HIV-infected women. AIDS (2006) 1.51
A side door into care cascade for HIV-infected patients? J Acquir Immune Defic Syndr (2013) 1.48
Incidence of acute urinary tract infection in young women and use of male condoms with and without nonoxynol-9 spermicides. Epidemiology (2002) 1.47
Changes in the transmission dynamics of the HIV epidemic after the wide-scale use of antiretroviral therapy could explain increases in sexually transmitted infections: results from mathematical models. Sex Transm Dis (2004) 1.45
Findings from SHAZ!: a feasibility study of a microcredit and life-skills HIV prevention intervention to reduce risk among adolescent female orphans in Zimbabwe. J Prev Interv Community (2010) 1.44
Work absence after breast cancer diagnosis: a population-based study. CMAJ (2005) 1.43
Preexposure prophylaxis will have a limited impact on HIV-1 drug resistance in sub-Saharan Africa: a comparison of mathematical models. AIDS (2013) 1.42
Assessing adult mortality in HIV-1-afflicted Zimbabwe (1998 -2003). Bull World Health Organ (2006) 1.42
Patterns of self-reported behaviour change associated with receiving voluntary counselling and testing in a longitudinal study from Manicaland, Zimbabwe. AIDS Behav (2009) 1.41
The association between cervical human papillomavirus infection and HIV acquisition among women in Zimbabwe. AIDS (2010) 1.40
Concurrent partnerships among adolescents in a Latino community: the Mission District of San Francisco, California. Sex Transm Dis (2007) 1.39
Audio computer-assisted self-interviewing in reproductive health research: reliability assessment among women in Harare, Zimbabwe. Contraception (2006) 1.37
The potential impact of pre-exposure prophylaxis for HIV prevention among men who have sex with men and transwomen in Lima, Peru: a mathematical modelling study. PLoS Med (2012) 1.35
Predictors of diaphragm use as a potential sexually transmitted disease/HIV prevention method in Zimbabwe. Sex Transm Dis (2005) 1.34
Effectiveness of HIV prevention strategies in resource-poor countries: tailoring the intervention to the context. AIDS (2006) 1.34
Determinants of contraceptive method among young women at risk for unintended pregnancy and sexually transmitted infections. Contraception (2003) 1.33
Advances in multilevel approaches to understanding the epidemiology and prevention of sexually transmitted infections and HIV: an overview. J Infect Dis (2005) 1.33
Barrier contraceptive method acceptability and choice are not reliable indicators of use. Sex Transm Dis (2003) 1.31
Effects of job strain on blood pressure: a prospective study of male and female white-collar workers. Am J Public Health (2006) 1.28
Not working 3 years after breast cancer: predictors in a population-based study. J Clin Oncol (2005) 1.28
Late entry to HIV care limits the impact of anti-retroviral therapy in The Netherlands. PLoS One (2008) 1.27
Vitamin D and calcium intakes from food or supplements and mammographic breast density. Cancer Epidemiol Biomarkers Prev (2005) 1.27
Understanding the potential impact of a combination HIV prevention intervention in a hyper-endemic community. PLoS One (2013) 1.26
Viral load monitoring of antiretroviral therapy, cohort viral load and HIV transmission in Southern Africa: a mathematical modelling analysis. AIDS (2012) 1.26
Oral and injectable contraception use and risk of HIV acquisition among women in sub-Saharan Africa. AIDS (2013) 1.25
Wolfe's parenchymal pattern and percentage of the breast with mammographic densities: redundant or complementary classifications? Cancer Epidemiol Biomarkers Prev (2003) 1.25
Synchronized seasonal variations of mammographic breast density and plasma 25-hydroxyvitamin d. Cancer Epidemiol Biomarkers Prev (2007) 1.24
Are Thai MSM willing to take PrEP for HIV prevention? An analysis of attitudes, preferences and acceptance. PLoS One (2013) 1.17
Understanding the modes of transmission model of new HIV infection and its use in prevention planning. Bull World Health Organ (2012) 1.14
HIV incidence, retention rate, and baseline predictors of HIV incidence and retention in a prospective cohort study of injection drug users in Xinjiang, China. Int J Infect Dis (2007) 1.13
Behavior change interventions to prevent HIV infection among women living in low and middle income countries: a systematic review. AIDS Behav (2010) 1.13
Consistent condom use in married Zimbabwean women after a condom intervention. Sex Transm Dis (2008) 1.13
HIV prevalence among injection drug users in rural Guangxi China. Addiction (2006) 1.11
Monitoring of antiretroviral therapy and mortality in HIV programmes in Malawi, South Africa and Zambia: mathematical modelling study. PLoS One (2013) 1.11
The effect of changes in condom usage and antiretroviral treatment coverage on human immunodeficiency virus incidence in South Africa: a model-based analysis. J R Soc Interface (2012) 1.10
Unprotected sex following HIV testing among women in Uganda and Zimbabwe: short- and long-term comparisons with pre-test behaviour. Int J Epidemiol (2009) 1.10
The future role of rectal and vaginal microbicides to prevent HIV infection in heterosexual populations: implications for product development and prevention. Sex Transm Infect (2011) 1.10
Only a fraction of new HIV infections occur within identifiable stable discordant couples in sub-Saharan Africa. AIDS (2013) 1.10
Household-based cash transfer targeting strategies in Zimbabwe: are we reaching the most vulnerable children? Soc Sci Med (2012) 1.08
HIV treatment as prevention: optimising the impact of expanded HIV treatment programmes. PLoS Med (2012) 1.08
Acceptability and use of the diaphragm and Replens lubricant gel for HIV prevention in Southern Africa. AIDS Behav (2009) 1.08
Evidence-based prevention: increasing the efficiency of HIV intervention trials. J Infect Dis (2004) 1.08
Influence of insulin-like growth factors on the strength of the relation of vitamin D and calcium intakes to mammographic breast density. Cancer Res (2006) 1.08
Couples who get closer after breast cancer: frequency and predictors in a prospective investigation. J Clin Oncol (2005) 1.07
Vaginal microbicides for HIV/STI prevention in Zimbabwe: what key informants say. J Transcult Nurs (2002) 1.07
Recent HIV prevalence trends among pregnant women and all women in sub-Saharan Africa: implications for HIV estimates. AIDS (2014) 1.06
Flaxseed on cardiovascular disease markers in healthy menopausal women: a randomized, double-blind, placebo-controlled trial. Nutrition (2007) 1.05
Out-of-pocket costs for accessing adjuvant radiotherapy among Canadian women with breast cancer. J Clin Oncol (2011) 1.03
Pharmacokinetics and placental transfer of single-dose tenofovir 1% vaginal gel in term pregnancy. J Infect Dis (2011) 1.03
Sexual behaviour in a rural high HIV prevalence South African community: time trends in the antiretroviral treatment era. AIDS (2013) 1.02
Increases in human papillomavirus detection during early HIV infection among women in Zimbabwe. J Infect Dis (2011) 1.01
The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa: results from three tuberculosis-HIV transmission models. AIDS (2014) 1.01